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CHAPTER 1: GENERAL INTRODUCTION 
 
 Total synthesis of biologically active natural products has been used for the 
discovery of new medicines. In collaboration with biology and medicinal chemistry, it 
has led to discovery and the ensuing syntheses of biologically potent natural products, 
which have been translated into drug applications.  
 
 In this thesis, we explored both total synthesis and methodology of several natural 
products and small molecules, especially using quinone as starting materials. Chapter 2 
describes an efficient synthesis of Bauhinoxepin J and polyhydroxylated xanthones via 
intramolecular radical cyclization, and a novel method of facile oxidation of 1,4-
hydroquinones to 1,4-benzoquinones by using N-Bromosuccinimide (NBS) was 
developed. Chapter 3 describes the direct synthesis of two ketone constituents, (Z)-
tetradeca-8-en-11,13-diyn-2-one and (8Z,13Z)-pentadeca-8,13-dien-11-yn-2-one from 
Echinacea pallida. Chapter 4 describes a synthesis of Uliginosins A and B. 
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CHAPTER 2: Synthesis of Natural Products and Small  
Molecules Using Quinones 
Part I: Concise Synthesis of Bauhinoxepin J Using 
Intramolecular Radical Cyclization 
 
Introduction 
 In recent years scientists have discovered a number of biologically active natural 
products bearing the dibenz[b,f]oxepin skeleton. Those compounds have been isolated 
from plants which belong to the Bauhinia genus, particularly from Bauhinia saccocalyx 
and Bauhinia purpurea.1–4 Several of these structurally unique natural products have been 
reported to exhibit attractive biological activities such as anti mycobacterial,1,3 anti 
malarial,1 anti fungal,1 cytotoxic,1,2,4 and anti-inflammatory1 activities. Representative 
structures are showed in Figure 1. Bauhinoxepin A (1) was isolated by Kittakoop et al in 
2004 from B. saccocalyx and shows anti mycobacterial activities with an MIC value of 
6.25 µm.3 Bauhiniastatin 1 (2) was isolated by Pettit et al from Bauhinia purpurea, 
exhibits significant growth inhibition against a mini-panel of human cancer cell lines, 
including the P388 cancer cell line.2 Bauhinoxepin J (3) was isolated by Kittakoop et al 
from B. purpurea in 2007.1 Although 3 appears to have a relatively simple structure, it 
exhibits remarkable biological activities including anti mycobacterial activity (MIC = 
24.4 µm), anti malarial activity (IC50 = 5.8 µm), and tumor growth inhibitory activity (KB 
cells: IC50 = 10.5 µm; BC cells: IC50 = 12.1 µm).1 Bulbophyol B (4), isolated from 
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Bulbophyllum kwangtungense by Wu in 2006, displays growth inhibition against human 
epithelial carcinoma (HeLa) and human erythomyeloblastoid leukaemia (K562) cell lines 
in the low micromolar range.4 
 
Figure 1 
 Bauhinoxepin J has a dihydrodibenzoxepin skeleton with a seven membered 
central ring flanked by a benzene ring on one side and a benzoquinone on the other. 
There have been two syntheses reported to make the dihydrodibenzoxepin skeleton. The 
first one involved acid-catalyzed rearrangement of xanthene-9-carbinol followed by 
reduction.5 The second method entailed tetrabromination of 2,2´-dimethyldiphenyl ether 
with N-bromosuccinimide followed by  cyclization (Scheme 1).6 
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Scheme 1 
 Kraus and coworkers have reported addition of radicals to substituted and 
unsubstituted quinones (Scheme 2).7-8 The radical was generated by combination of 
ammonium persulfate in presence of a catalytic amount of silver nitrate. 
 
Scheme 2 
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 Because of the benzoquinone part in Bauhinoxepin J and the above intermolecular 
radical addition to benzoquinones, we decided to apply intramolecular radical addition to 
benzoquinone as a key step to form Bauhinoxepin J. To the best of our knowledge, there 
is no evidence for the intramolecular radical addition to a quinone to make a seven 
membered ring.  
 
Results and Discussion 
 As shown in the retrosynthetic analysis, we envisioned that 3 could be assembled 
via C-O bond formation followed by radical cyclization. This pathway directed us to our 
starting materials: 2-(3-hydroxypropyl) phenol (4) and 2-bromo-5-methoxy-1,4-
benzoquinone (5) (Scheme 3). 
 
Scheme 3 
 The diol 4 was prepared by treating dihydrocoumarin 6 with lithium aluminum 
hydride9 and the benzoquinone 5 was made in two steps from 1,2,4 trimethoxybenzene 
7.10-11 Coupling of 4 and 5 was achieved by using potassium carbonate as a base in DMF 
to give alcohol 9 in 90% yield. The primary alcohol 9 was then oxidized to the carboxylic 
acid 10 using Jones’ reagent in 81% yield (Scheme 4). 
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Scheme 4 
 The stage was set for us to try the pivotal decarboxylative radical cyclization. 
First, we attempted to use phenyliodoso diacetate12,13 to generate the radical from 10 
(Scheme 5). To our disappointment, it provided a meager 4% yield of the target 
compound. We next employed the Barton ester14,15 protocol. Unfortunately, this method 
did not provide any of the desired products. We then examined the silver catalyzed 
persulfate method developed by Torssell and by Minisci.16-17 Fortunately, the use of 
ammonium persulfate with equivalent proportions of the silver salt afforded 3 in 30% 
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isolated yield as the only identifiable product. We also tried using potassium persulfate 
instead of ammonium persulfate; however, it provided only a 13% yield of 3. The 
conditions of DeKimpe,18 wherein both the silver salt and the persulfate were added in 
two portions, afforded 3 in 40% isolated yield. This constitutes a 25% overall yield of 
Bauhinoxepin J. The identity of synthetic Bauhinoxepin J (3) was confirmed by 
comparison of our 1H NMR, 13C NMR, LRMS, and HRMS data with the published 
spectra. 
 
Scheme 5 
 The mechanism of silver (I) catalyzed persulfate reaction is shown below as 
proposed by Minisci.17 
 (i) Generation of carbon centered radical 
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 (ii) Addition to quinone 
 
 (iii) Oxidation of the radical adduct in a redox chain 
 
 
Conclusion 
 This represents the first total synthesis of Bauhinoxepin J (3). This synthesis 
features the first intramolecular radical addition to a quinone. This flexible and direct 
synthetic pathway will facilitate further biological evaluation of this little studied class of 
natural products. 
 
Experimental 
 Unless otherwise noted, materials were obtained from commercial suppliers and 
used without purification. Nuclear magnetic resonance experiments were performed with 
either a Varian 300 MHz or a Varian 400 MHz instrument. High resolution mass spectra 
were recorded on a Kratos model MS-50 spectrometer and low resolution mass spectra 
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were performed with a Finnegan TSQ700 mass spectrometer. Standard grade silica gel 
(60 Å, 32-63 µm) was used for flash column chromatography. 
 
Compound 3 
 To a stirred solution of acid 10 (16 mg, 0.053 mmol) in 6 mL of 30% aq CH3CN 
under argon was added silver nitrate (0.3 equiv). The mixture was heated to 65 °C and a 
solution of ammonium persulfate (1.3 equiv) in 2 mL of 30% aq CH3CN was added 
dropwise for 20 min. The mixture was then stirred at 70 °C for 3 h. The mixture was 
cooled to 65 °C. An additional amount of silver nitrate (0.3 equiv) was added and a 
solution of ammonium persulfate (1.3 equiv) in 2 mL of 30% aq CH3CN was added 
dropwise for 20 min. After an additional 3 h at 70 °C, the reaction mixture was cooled to 
room temperature and extracted with dichloromethane. The organic extracts were washed 
with brine, dried over Na2SO4, and evaporated in vacuo. The residue was purified using 
flash chromatography on silica gel (1:1 hexanes:ethyl acetate) to obtain 3 (5.5 mg,40% 
yield). 
1H NMR (300 MHz, CDCl3): 7.22–7.25 (m, 2H), 7.13–7.17 (m,2H), 5.90 (s, 1H), 3.83 (s, 
3H), 3.06–3.09 (m, 2H), 2.81–2.85 (m, 2H).  
13C NMR(100 MHz, CDCl3): 182.8, 181.9, 158.9, 155.7, 152.9, 133.2, 129.6, 128.0, 
126.0,123.7, 121.2, 105.4, 56.7, 29.9, 26.5. 
LRMS (EI): m/z 256 (M+, 100%), 241, 115,69; HRMS (EI) calcd for C15H12O4: 
256.0736, found: 256.0740. 
 
 
10 
 
Compound 4 
 To a suspension of lithium aluminum hydride (0.62 g, 16.2mmol) in diethyl ether 
(15 mL) at 0 °C, was added 3,4-dihydrocoumarin 6 (1.71 mL, 13.5mmol) in diethyl ether 
(15 mL). The reaction mixture was gently warmed to room temperature and then heated 
to reflux for 4 h, after which, it was cooled to room temperature. Then 0.6 mL water, 0.6 
mL of 15% aqueous NaOH solution and 1.8 mL water were then added, successively, to 
quench the reaction. The resulting solution was diluted with ethyl acetate, washed with 
water and brine,successively. The organic layer was dried over Na2SO4, evaporated in 
vacuo. The residue was purified by flash column chromatography on silica gel 
(dichloromethane : ethyl acetate = 4:1) to afford 4 (1.75 g, 85% yield). 
1H NMR (400MHz, CDCl3): 7.14-7.10 (m, 2H), 7.05 (s, 1H), 6.90-6.84 (m, 2H), 3.66 (t, 
2H, J = 6.0 Hz),2.79 (t, 2H, J = 6.8 Hz), 2.46 (s, 1H), 1.93-1.86 (m, 2H). 
 
Compound 5 
 To a solution of 8 (1g, 4.05 mmol) in acetonitrile : water (1:2, 45 mL) was added 
ceric ammonium nitrate (6.0 g, 10.93mmol). After 3 h at room temperature, the reaction 
mixture was diluted with ethyl acetate, washed with water and brine, successively. The 
organic layer was dried over Na2SO4 and evaporated in vacuo. The residue was purified 
by flash column chromatography on silica gel (ethyl acetate) to afford 5 (0.75 g, 85% 
yield).  
1HNMR (400 MHz, CDCl3): 7.25 (s, 1H), 6.14 (s, 1H), 3.87 (s, 3H). 
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Compound 8 
 To a solution of 7 (1.0 g, 5.95 mmol) in dichloromethane (20 mL) at 0 °C was 
added bromine (0.34 mL, 6.54 mmol) in dichloromethane (5 mL). After stirring for 2.5 h 
at the same temperature, saturated aqueous sodium thiosulfate solution was added to 
quench the reaction. The resulting solution was diluted with dichloromethane, washed 
with water and brine, successively. The organic layer was dried Na2SO4 and evaporated 
in vacuo. The residue was purified by flash column chromatography on silica gel 
(hexanes : ethyl acetate = 3:1) to afford 8 (1.44 g, 98% yield). 
1H NMR (400 MHz, CDCl3) : 7.04 (s, 1H), 6.57 (s, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 3.84 
(s, 3H). 
 
Compound 9 
 To a solution of 4 (220 mg, 1.44 mmol) in DMF (5 mL) was added potassium 
carbonate (200 mg, 1.44 mmol). After 30 min at room temperature , 5 (300 mg, 1.38 
mmol) in DMF  (10 mL) was added to the reaction mixture. The mixture was stirred at 
room temperature for additional 3.5 h upon which it was quenched with 1N HCl. The 
resulting solution was diluted with ethyl acetate, washed with water and brine, 
successively. The organic layer was dried Na2SO4 and evaporated in vacuo. The residue 
was purified by flash column chromatography on silica gel (hexanes : ethyl acetate = 1:1) 
to afford 12 (358 mg, 90% yield). 
1H NMR (400 MHz, CDCl3):  7.31 (dd, 1H, J = 6.8 Hz, 2.4 Hz), 7.28-7.21 (m, 2H), 7.00 
(dd, 1H, J = 7.2 Hz, 2.0 Hz), 5.95 (s, 1H), 5.58 (s, 1H), 3.85 (s, 3H), 3.58 (s, 2H), 2.58 (t, 
2H, J = 7.2 Hz) 2.23 (s, 1H), 1.83-1.77 (m, 2H). 
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13C NMR (100 MHz , CDCl3): 181.9, 181.7, 159.7, 158.9, 150.7, 133.8, 131.6, 128.1, 
127.3, 121.1, 108.5, 105.7, 61.2, 56.9, 33.5, 25.8. 
 
Compound 10 
 To a solution 9 (125 mg, 0.43 mmol) in acetone (10 mL) at 0 °C was added 8N 
Jones reagent (1.5 mL). The mixture was stirred at the same temperature for additional 
3.5 h upon which 2-propanol was added to consume the excess Jones reagent. The 
solution was then evaporated in vacuo. The resulting residue was diluted with ethyl 
acetate, washed with water and brine, successively. The organic layer was dried over 
Na2SO4 and evaporated in vacuo. The residue was purified by flash column 
chromatography on silica gel (ethyl acetate) to afford 10 (105 mg, 81% yield).  
1H NMR (400MHz, CDCl3): 7.31 (dd, 1H, J = 7.2 Hz, 1.6 Hz), 7.31-7.23 (m, 2H), 7.02 
(dd, 1H, J = 8.0 Hz, 1.6 Hz), 5.97 (s, 1H), 5.58 (s, 1H), 3.88 (s, 3H), 2.85 (t, 2H, J = 7.6 
Hz), 2.67 (t, 2H, J = 7.6 Hz). 
13C NMR (100 MHz , CDCl3): 182.0, 181.4, 177.7, 159.6, 159.1, 150.8, 132.2, 131.2, 
128.8, 127.3, 121.5, 108.8, 105.9, 56.9, 34.0, 25.0. 
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Part II: Synthesis of PolyhydroxylatedXanthones 
via Acyl Radical Cyclizations and Facile Oxidation of  
1,4-Hydroquinones to 1,4-Benzoquinones Using NBS 
 
Introduction 
 Xanthones are found in many plants, including Hypericum and Prunella species. 
Many xanthones bearing hydroxyl substituents exhibit valuable biological activity.1 
Daviditin A (1) preserves endothelial dysfunction elicited by lysophosphatidyl choline 
(Fig. 1). The protective effect of daviditin A on the endothelium is related to reduction of 
asymmetric dimethylarginine concentration.2 Xanthone 2 was shown to relax the corpus 
cavernosal smooth muscle by 97% compared to Viagra.3 Bellidifolin (3) improved insulin 
resistance by enhancing insulin signaling.4 
 
 
Figure 1  
Because of the diverse biological activities of xanthones, several approaches have 
been reported.5 Of these methods, Friedel–Crafts acylation/cyclization protocols6 are the 
most commonly used methods. However, synthetic methods for highly hydroxylated 
xanthones are limited. Recently, Kraus developped a photo acylation reaction.7 Okuma8a 
15 
 
and Larock8b reported benzyne additios. Snieckus9a and Argade9b employed directed 
metallations. We report herein a synthesis of polyhydroxylated xanthones employing acyl 
radical intermediates, meanwhile, we also found NBS can oxidize 1,4-hydroquinone to 
1,4-benzoquinone. 
 
Results and Discussion 
 We recently reported that radicals generated by decarboxylationof an acid with 
persulfate underwent intramolecular cyclizationto a quinone, resulting in a direct 
synthesis of Bauhinoxepin J.10 If an acyl radical could be generated from 6,11 the 
cyclization could lead to a direct synthesis of xanthones (Scheme 1). The quinone 6 can 
be synthesized by a coupling reaction of acetal 4 with bromoquinone 5. 
 Scheme 1 
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 We first tried directly coupling salicyladehyde with bromoquinone 5 to generate 
quinone 6, but the reaction failed (Scheme 2). Then we decided to protect carbonyl group 
first. All attempts to convert salicylaldehyde to a cyclic acetal failed.12-14 Conversion of 
salicyladehyde to acylic acetal 4 was achieved by using TiCl4 as a catalyst.15 The reaction 
of acetal 4 with bromoquinone 5 andK2CO3 in DMF followed by HCl hydrolysis afforded 
quinone 6 in 78% yield. 
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Scheme 2 
To the best of our knowledge, there have been no reports for the synthesis of 
xanthones from quinones such as 6. Initially, we irradiated quinone 6 under conditions 
where an intramolecular hydrogen atom abstraction via an excited state quinone could 
lead to an acyl radical (scheme 3). Unfortunately, only starting material was recovered. 
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We next attempted to generate the acyl radical through hydrogen atom abstraction using 
the diradical of benzophenone, a strategy we had used successfully to generate 
acylhydroquinones.16 This approach also failed. 
 
 
Scheme 3 
 Cheung and later Marko reported that aryl aldehydes could be converted to acid 
bromides with NBS (Scheme 4).17 Although this transformation has not been extensively 
studied, this reaction likely proceeds through an acyl radical intermediate.  
 
Scheme 4 
Treatment of quinone 6 with two equivalent of NBS and a catalytic amount of 
AIBN in CHCl3 and CCl4 produced xanthone 7 (scheme 5). A number of experiments 
were conducted to optimize thetransformation and it was found that two equivalents of 
NBS and 0.2 equiv of AIBN were necessary to achieve good conversion. Unfortunately, 
xanthone 7 was not stable to column chromatography. The xanthone 7 was reduced by 
catalytic hydrogenation to generate xanthone 9, albeit in only 15% yield after two steps. 
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The structure of xanthone 9 was confirmed by X-ray spectroscopy (Fig. 2). Reduction of 
xanthone 7 with zinc in acetic acid afforded benzophenone 8 in 67% yield after two steps, 
whose structure was also determined by X-ray spectroscopy (Fig. 3). This appears to be 
the first example of xanthone cleavage under reductive conditions. Benzophenone 8 
could be readily cyclized to form xanthone 9 by heating in aqueous DMF at 180 °C for 
16 h in 77% yield.7 Xanthone 9 is produced in an overall yield of 40%. Interestingly, 
benzophenone 8 is a natural product isolated from Dalbergia cochinchinensis.18 This is 
the first report of its synthesis. 
 
Scheme 5 
20 
 
Figure 2 
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Figure 3 
Moreover, this result was unexpected and suggests that production of xanthone 7 
arises from a spirocyclic intermediate such as 10 that would result from a 5-exo-trig 
radical cyclization. Elimination of the phenoxide radical followed by cyclization and 
oxidation providesa route to 7 (Scheme 6). Attempts to isolate intermediates in the 
rearrangement by conducting the reaction using only one equivalent of NBS produced 
starting material plus a reduced yield of 7. It is possible that the mechanism involves a 6-
endo closure followed by arearrangement. 
22 
 
 
Scheme 6 
 This procedure was applied to other bromoquinones. The results in Table 1show 
the quinone precursors that were synthesized. The overall yields are in the range of 52–
78%. 
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Table 1. Reaction of 4 with 5 to Generate Quinone 6 
O
O
O
O
6
OH
O
O
O
O
Br
+
4 5
1.K2CO3 , DMF
RT, 4h
2.6N HCl
RT, 1h
G1
G2 G1 G2
 
Entry 4 5 6 
Isolated 
Yield(%) 
 
 
1    
 
78 
 
 
 
2 
 
  
 
76 
 
 
3  
 
O
O
O
O
O
Cl
 
 
73 
 
 
4    
 
58 
 
 
5    
 
52 
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 The xanthones in Table 2 were prepared from the corresponding quinones by 
cyclization with AIBN and NBS, reduction with zinc, and cyclization in DMF/water. The 
xanthone in entry 2 is a natural product isolated from Centaurium erythraea19 that had not 
previously been synthesized. The overall yields for different xanthonesare 40% (entry 1), 
36% (entry 2), 31% (entry 3), 29% (entry 4), and30% (entry 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Table 2. Reaction of Quinone 6 to Generate 8 and Xanthone 9 
 
Entry          6          8a 
Isolated 
Yield(%) 
       9b 
Isolated 
Yield(%) 
 
 
1 
  
 
 
86 
 
 
77 
 
 
 
2  
  
 
 
65 
 
 
72 
 
 
3 
 
 
 
 
 
75 
 
 
 
70 
 
 
4 
 
 
 
 
 
81 
 
O
O
OH
OH  
 
73 
 
 
5 
 
 
 
 
 
84 
 
 
 
77 
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a
 Entry 1 is a natural product isolated from Dalbergiacochinchinensis. 
b
 Entry 2 is a natural product isolated from Centauriumerythraea. 
 
The proposed mechanism is shown below. 
 
 
 
 Based on the mechanism, we should get hydroxylated xanthone e directly. 
Unfortunately, attempts to isolate compound e failed. We finanlly obtained compound 7 
instead. We realized maybe this result was due to oxidation of compound e by NBS. 
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From compound e to compound 7, only hydroquinone ring was changed to benzoquinone 
ring. Then we thouhgt, maybe NBS could oxidaze 1,4-hydroquinone to 1,4-benzoquinone. 
Interestingly, no one reported this result before. After many experiments, we found we 
could successfully oxidize 1,4-hydroquinone to 1,4-benzoquinone by using 1.1 equivalent 
NBS, THF and water as solvent. Table 3 showed the results. 
Table 3. Oxidation of 1,4-Hydroquinone to 1,4-Benzoquinone 
 
Entry Starting Material Product Isolated 
Yield(%) 
 
1 
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 This method works fine for simple 1,4-hydroquinones with good yields. Entry 1 to entry 
5 show that from the simplest 1,4-hydroquinone to di-substituted 1,4-hydroquinone, the yields are 
from 91% to 96%. This method also works fine for chloro (entry 6) and bromo (entry 7) 
substituted 1,4-hydroquinone, especially entry 7. Because the 2-bromo-1,4-benzoquinone is really 
expensive, it is possible to make it with low price with this method. This method not only works 
for simple 1,4-hydroquinone, but also works for complicated 1,4-hydroquinone, entry 8 to 10. 
Those related 1,4-benzoquinone are not easy to make. But by using NBS, it is easy to make them 
with good yields. When we tried β-keto 1,4-hydroquinone, entry 11 and 12, both reactions failed. 
The reason is probably that both β-keto groups are electron withdrawing group which can result 
in electron deficient on the benzene ring. 
 
The proposed mechanism is shown below. 
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Conclusion 
 In summary, the first synthesis of xanthones by acyl radical chemistry has been 
achieved. Two natural products were synthesized. This novel approach will permit the 
direct synthesis of novel polyhydroxylated xanthones. And a new method of oxidation of 
1,4-hydroquinone to 1,4-benzoquinone is developped. 
 
Experimental 
 Unless otherwise noted, materials were obtained from commercial suppliers and 
used without purification. All 1H and 13C NMR spectra were recorded at 300 (400) MHz 
and 100 MHz respectively. High resolution mass spectra were recorded on a Q-TOF mass 
spectrometer. X-ray spectra were recorded by Bruker APEX2 CCD system . Standard 
grade silica gel (60 Å, 32-63 µm) was used for flash column chromatography.  
 
Representative procedure for quinone (6) 
 
 
 
 To a solution of 4 (185 mg, 1.1 mmol) in 11 ml of dry DMF was added K2CO3 
(152 mg, 1.1 mmol) at room temperature under argon. After stirring for 30 min, the 
solution of 5 (217 mg, 1.0 mmol) in 10 ml of dry DMF was added dropwise. The mixture 
was stirred for 3.5 hours. Then 4 ml of 6N HCl was added. After stirring for 1 hour, the 
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resulting mixture was extracted with ethyl acetate (3 × 10 ml). The organic phase was 
washed with brine, dried over anhydrous Na2SO4 and evaporated in vacuo. Residue was 
purified by column chromatography (Hexanes : EtOAc = 3:1) to give pure product. 
 
 
 
Yield = 78%; 1H NMR (300MHz, CDCl3):  10.12 (s, 1H), 7.99-7.96 (dd, J=3.0, 6.0 Hz, 
1H), 7.73-7.67 (dt, J=3.0, 9.0 Hz, 1H), 7.49-7.44 (t, J=6 Hz, 1H), 7.19-7.16 (d, J=9.0, 1H), 
5.99 (s, 1H), 5.62 (s, 1H), 3.87 (s, 3H); 13C NMR (100MHz, CDCl3): 187.7, 181.6, 180.7, 
159.6, 159.3, 154.3, 136.3, 131.1, 127.9, 127.5, 122.3, 110.0, 105.9, 57.0. 
 
 
 
 
Yield = 76%; 1H NMR (400MHz, CDCl3):  10.11 (s, 1H), 7.51-7.49 (d, J=8.0 Hz, 1H), 
7.40-7.36 (t, J=8.0 Hz, 1H), 7.26-7.24 (d, J=8.0 Hz, 1H), 5.96 (s, 1H), 5.53 (s, 1H), 3.86 
(s, 3H), 3.83 (s, 3H); 13C NMR (100MHz, CDCl3): 187.9, 181.8, 180.7, 159.5, 158.3, 
151.1, 143.0, 129.0, 127.8, 121.0, 118.6, 109.2, 105.8, 56.9, 56.5. 
 
 
 
Yield = 73%; 1H NMR (300MHz, CDCl3):  10.08 (s, 1H), 7.93-7.92 (d, J=3.0 Hz, 1H), 
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7.65-7.62 (dd, J=3.0, 9.0 Hz, 1H), 7.14-7.11 (d, J=9.0 Hz, 1H), 5.98 (s, 1H), 5.67 (s, 1H), 
3.87 (s, 3H); 13C NMR (100MHz, CDCl3): 186.4, 181.3, 180.5, 159.6, 158.8, 152.9, 
136.0, 133.4, 130.4, 128.8, 123.6, 110.6, 105.9, 57.0. 
 
 
 
Yield = 58%; 1H NMR (300MHz, CDCl3):  10.12 (s, 1H), 7.99-7.96 (dd, J=3.0, 9.0 Hz, 
1H), 7.73-7.67 (dt, J=3.0, 9.0 Hz, 1H), 7.49-7.44 (t, J=9.0 Hz, 1H), 7.18-7.15 (d, J=9.0 
Hz, 1H), 6.86-6.83 (d, J=9.0 Hz, 1H), 6.77-6.73 (dd, J=3.0, 12.0 Hz, 1H), 5.70 (s, 1H); 
13C NMR (100MHz, CDCl3): 187.8, 187.3, 180.9, 158.4, 154.1, 137.2, 136.3, 134.9, 
131.2, 127.9, 127.4, 122.3, 112.3. 
 
 
 
Yield = 52%; 1H NMR (300MHz, CDCl3):  10.09 (s, 1H), 7.99-7.96 (dd, J=3.0, 9.0 Hz, 
1H), 7.74-7.68 (dt, J=3.0, 9.0 Hz, 1H), 7.52-7.47 (t, J=9.0 Hz, 1H), 7.35 (s, 1H), 7.19-
7.16 (d, J=9.0 Hz, 1H), 5.86 (s, 1H); 13C NMR (100MHz, CDCl3): 187.7, 179.2, 178.4, 
158.7, 153.5, 139.0, 136.4, 136.1, 131.8, 127.7, 122.3, 111.3, 111.2. 
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Representative procedure for benzophenone (8) 
 
 
 
 
 To the mixture of 6 (54 mg, 0.21 mmol), AIBN (7 mg, 0.042 mmol) and NBS (75 
mg, 0.42 mmol) was added 2 ml of CHCl3 and 6 ml of CCl4 at room temperature under 
argon. The resulting mixture was boiled for 4 hours. After cooling to room temperature, 
the solvents were removed in vacuo. The residue was dissolved in 6 ml AcOH. After Zn 
metal powder (137 mg, 2.1 mmol) was added, the resulting mixture was stirred at room 
temperature for 10 min. The reaction mixture was filtered through celite and diluted with 
CH2Cl2,followed by washing twice with water. The organic phase was washed with brine, 
dried over anhydrous Na2SO4 and evaporated in vacuo. Residue was purified by column 
chromatography (Hexanes : EtOAc = 1:1) to give pure product. 
 
 
 
Yield = 86%. 1H NMR and 13C NMR are as same as reference.1 
(1. Pathak, Vibha; Shirota, Osamu; Sekita, Setsuko; Hirayama, Yutaka; Hakamata, 
Yusuke; Hayashi, Tatsuo; Yanagawa, Takuma; Satake, Motoyoshii; 
Phytochemistry.1997, 46(7), 1219-1223.) 
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Yield = 65%; 1H NMR (300MHz, DMSO-d6):  12.18 (s, 1H), 9.29 (br s, 1H), 8.80 (br s, 
1H), 7.13-7.09 (dd, J=3.0, 9.0 Hz, 1H), 6.92-6.87 (t, J=6.0 Hz, 1H), 6.81-6.78 (dd, J=3.0, 
9.0 Hz, 1H), 6.68 (s, 1H), 6.56 (s, 1H), 3.85 (s, 3H), 3.84 (s, 3H); 13C NMR (100MHz, 
DMSO-d6): 199.8, 157.8, 155.8, 147.7, 143.6, 138.9, 126.3, 119.8, 119.2, 117.0, 113.3, 
112.3, 100.1, 56.0, 55.9. HRMS (M-1) calcd for C15H13O6: 289.0718; found: 289.0726. 
 
 
 
Yield = 75%; 1H NMR (300MHz, DMSO-d6): 7.40-7.36 (dd, J=3.0, 9.0 Hz, 1H), 7.28 (s, 
1H), 6.99-6.96 (d, J=9.0 Hz, 1H), 6.68 (s, 1H), 6.56 (s, 1H), 3.84 (s, 3H); 13C NMR 
(100MHz, DMSO-d6): 198.0, 158.0, 156.2, 153.3, 139.1, 131.0, 127.7, 122.4, 119.5, 
118.0, 116.7, 112.0, 100.1, 56.0.   HRMS (M-1) calcd for C14H10ClO5: 293.0222; found: 
293.0231. 
 
OH
O
OH
OH  
 
Yield = 81%; 1H NMR (300MHz, DMSO-d6): 10.83 (s, 1H), 10.57 (s, 1H), 9.83 (s, 1H), 
7.49-7.43 (dt, J=3.0, 9.0 Hz, 1H), 7.36-7.33 (dd, J=3.0, 9.0 Hz, 1H), 7.00 (s, 1H), 6.97-
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6.88 (m, 4H); 13C NMR (100MHz, DMSO-d6): 200.6, 157.6, 150.8, 145.5, 134.2, 131.0, 
125.8, 123.3, 122.2, 119.1, 117.7, 117.4, 116.8.   HRMS (M-1) calcd for C13H9O4: 
229.0506; found: 229.0508. 
 
 
 
Yield = 84%; 1H NMR (300MHz, CDCl3): 7.63-7.60 (d, J=9.0 Hz, 1H), 7.55-7.49 (dt, 
J=3.0, 9.0 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 7.09-7.06 (dd, J=3.0, 9.0 Hz, 1H), 6.97-
6.92 (t, J=9.0 Hz, 1H); 13C NMR (100MHz, DMSO-d6): 201.4, 162.0, 155.2, 144.9, 136.5, 
132.9, 125.8, 121.9, 120.1, 119.7, 119.3, 118.9, 118.4.   HRMS (M-1) calcd for 
C13H8BrO4: 306.9611; found: 306.9617. 
 
Representative procedure for xanthone (9) 
 
 
 
 To 8 (23 mg, 0.088 mmol) in a sealable tube was added 1.7ml of DMF and 2.7 ml 
of H2O. The resulting mixture was heated at 180°C for 16 hours. After cooling to room 
temperature, the reaction mixture was diluted with EtOAc,followed by washing twice 
with water. The organic phase was washed with brine, dried over anhydrous Na2SO4 and 
evaporated in vacuo. Residue was purified by column chromatography (Hexanes : EtOAc 
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= 1:1) to give pure product. 
 
 
 
 
 
Yield = 77%; 1H NMR (300MHz, DMSO-d6):  12.40 (s, 1H), 8.90 (br s, 1H), 8.16-8.13 
(dd, J=3.0, 9.0 Hz, 1H), 7.90-7.84 (dt, J=3.0, 9.0 Hz, 1H), 7.63-7.61 (d, J=6 Hz, 1H), 
7.49-7.44 (t, J=6.0 Hz, 1H), 6.58 (s, 1H), 3.93 (s, 3H); 13C NMR (100MHz, DMSO-d6): 
180.6, 155.8, 155.6, 154.7, 143.9, 135.9, 126.0, 125.3, 124.2, 119.6, 117.8, 102.5, 94.7, 
56.4.       
HRMS (M-1) calcd for C14H9O5: 257.0455; found: 257.0452. 
 
 
 
Yield = 72%; 1H NMR (300MHz, DMSO-d6): 12.44 (s, 1H), 8.75 (br s, 1H), 7.69-7.66 
(dd, J=3.0, 9.0 Hz, 1H), 7.53-7.49 (dd, J=3.0, 9.0 Hz, 1H), 7.40-7.35 (t, J=6.0 Hz, 1H), 
6.59 (s,1H), 3.98 (s, 3H), 3.94 (s, 3H); 13C NMR (100MHz, DMSO-d6): 180.7, 155.9, 
154.7, 148.2, 145.8, 144.1, 126.1, 123.8, 120.3, 116.9, 115.8, 102.5, 94.7, 56.5, 56.3. 
HRMS (M-1) calcd for C15H11O6: 287.0561; found: 287.0567. 
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Yield = 70%; 1H NMR (300MHz, DMSO-d6): 12.17 (s, 1H), 8.97 (br s, 1H), 8.07-8.06 (d, 
J=3.0 Hz, 1H), 7.92-7.88 (dd, J=3.0, 9.0 Hz, 1H), 7.68-7.65 (d, J=9.0 Hz, 1H), 6.61 (s, 
1H), 3.94 (s, 3H); 13C NMR (100MHz, DMSO-d6): 56.6, 95.1, 102.4, 120.4, 120.8, 124.3, 
126.2, 128.5, 135.6, 143.7, 154.3, 154.8, 156.2, 179.5. HRMS (M-1) calcd for C14H8ClO5: 
291.0066; found: 291.0072. 
 
 
 
Yield = 73%; 1H NMR (300MHz, DMSO-d6): 11.84 (s, 1H), 9.72 (br s, 1H), 8.20-8.17 
(dd, J=3.0, 9.0 Hz, 1H), 7.95-7.89 (dt, J=3.0, 9.0 Hz, 1H), 7.68-7.66 (d, J=6.0 Hz, 1H), 
7.53-7.48 (t, J=9.0 Hz, 1H), 7.31-7.28 (d, J=9.0 Hz, 1H), 6.68-6.66 (d, J=6.0 Hz, 1H); 13C 
NMR (100MHz, DMSO-d6): 181.9, 155.6, 152.4, 143.7, 137.4, 136.4, 125.5, 124.5, 
123.7, 119.8, 118.2, 114.9, 109.0. HRMS (M-1) calcd for C13H7O4: 227.0350; found: 
227.0356. 
 
 
 
Yield = 77%; 1H NMR (300MHz, DMSO-d6): 11.91 (br s, 1H), 8.20-8.16 (dd, J=3.0, 9.0 
Hz, 1H), 7.98-7.92 (dt, J=3.0, 9.0 Hz, 1H), 7.68-7.66 (d, J=6.0 Hz, 1H), 7.56-7.50 (dt, 
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J=3.0, 9.0 Hz, 1H), 7.02 (s, 1H), 6.88 (s, 1H); 13C NMR (100MHz, DMSO-d6): 181.5, 
155.3, 152.5, 136.6, 135.3, 125.4, 124.9, 119.8, 119.5, 118.1, 112.5, 109.7, 108.2.   
HRMS (M-1) calcd for C13H6BrO4: 304.9455; found: 304.9457. 
 
X-Ray Data 
1. Benzophenone 8  
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A yellow plate-like specimen of C14H12O5, approximate dimensions 0.05 mm x 0.10 mm 
x 0.29 mm, was used for the X-ray crystallographic analysis. Crystal was selected under 
the microscope and covered with PARATONE oil. After that sample was mounted in 
diffractometer under the stream of cold nitrogen.  The X-ray intensity data were 
measured using BRUKER APEX2 CCD diffractometer. 
The total exposure time was 8.97 hours. The frames were integrated with the Bruker 
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SAINT software package using a narrow-frame algorithm. The integration of the data 
using a monoclinic unit cell yielded a total of 8268 reflections to a maximum θ angle of 
25.07° (0.84 Å resolution), of which 2056 were independent (average redundancy 4.021, 
completeness = 99.9%, Rint = 6.42%, Rsig = 5.50%) and 1390 (67.61%) were greater than 
2σ(F2). The final cell constants of a = 9.957(4) Å, b = 3.8623(15) Å, c = 30.418(13) Å, β 
= 97.709(5)°, volume = 1159.2(8) Å3, are based upon the refinement of the XYZ-
centroids of 1169 reflections above 20 σ(I) with 5.229° < 2θ < 44.30°. Data were 
corrected for absorption effects using the multi-scan method (SADABS). The ratio of 
minimum to maximum apparent transmission was 0.813. The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.9676 and 0.9943.  
 
All non-hydrogen atoms were refined in full-matrix anisotropic approximation based on 
F2 . All expected hydrogen atoms were placed on a calculated positions and were refined 
in isotropic approximation using "riding" model. The Uiso(H) values have been set at 
1.2  - 1.5  times the Ueq value of the carrier atom. with 176 variables converged at R1 = 
5.66%, for the observed data and wR2 = 14.02% for all data. The goodness-of-fit was 
1.046. The largest peak in the final difference electron density synthesis was 0.264 e-/Å3 
and the largest hole was -0.235 e-/Å3 with an RMS deviation of 0.060 e-/Å3. On the basis 
of the final model, the calculated density was 1.491 g/cm3 and F(000), 544 e-. 
 
Table 1. Sample and crystal data for Benzophenone8. 
Chemical formula  C14H12O5 
Formula weight  260.24 
Temperature  173(2) K 
Wavelength  0.71073 Å 
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Crystal size  0.05 x 0.10 x 0.29 mm 
Crystal habit  yellow plate 
Crystal system  monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions  a = 9.957(4) Å  α = 90° 
 
b = 3.8623(15) Å  β = 97.709(5)° 
 
c = 30.418(13) Å  γ = 90° 
Volume  1159.2(8) Å3 
 
Z  4 
Density (calculated)  1.491 Mg/cm3 
Absorption coefficient  0.114 mm-1 
F(000)  544 
 
Table 2. Data collection and structure refinement for 
Benzophenone8.  
Theta range for data 
collection  1.35 to 25.07° 
Index ranges  -11<=h<=11, -4<=k<=4, -36<=l<=36 
Reflections collected  8268 
Independent reflections 2056 [R(int) = 0.0642] 
Coverage of 
independent reflections  99.9% 
Absorption correction  multi-scan 
Max. and min. 
transmission  0.9943 and 0.9676 
Structure solution 
technique  direct methods 
Structure solution 
program  SHELXS-97 (Sheldrick, 2008) 
Refinement method  Full-matrix least-squares on F2 
Refinement program  SHELXL-97 (Sheldrick, 2008) 
Function minimized  Σ w(Fo2 - Fc2)2 
Data / restraints / 
parameters  2056 / 0 / 176 
Goodness-of-fit on F2 1.046 
∆/σmax 0.001 
Final R indices  1390 data; I>2σ(I)  
R1 = 0.0566, wR2 = 
0.1264 
 
all data  R1 = 0.0911, wR2 = 0.1402 
42 
 
Weighting scheme  w=1/[σ
2(Fo2)+(0.0494P)2+1.4709P] 
where P=(Fo2+2Fc2)/3 
Largest diff. peak and 
hole  0.264 and -0.235 eÅ
-3
 
R.M.S. deviation from 
mean  
0.060 eÅ-3 
 
Table 3. Atomic coordinates and 
equivalent isotropic atomic displacement 
parameters (Å2) for Benzophenone8.  
U(eq) is defined as one third of the trace of 
the orthogonalizedUij tensor.  
 
x/a  y/b  z/c  U(eq) 
O1 0.1737(2) 0.5995(6) 0.92261(7) 0.0290(6) 
O2 0.6455(2) 0.8167(6) 0.96285(7) 0.0315(6) 
O3 0.8047(2) 0.5550(7) 0.91270(7) 0.0361(6) 
O4 0.9572(2) 0.2118(7) 0.86563(7) 0.0333(6) 
O5 0.2227(2) 0.2734(7) 0.84832(7) 0.0310(6) 
C1 0.1417(3) 0.7741(9) 0.96110(11) 0.0319(8) 
C2 0.3058(3) 0.5889(8) 0.91532(10) 0.0235(7) 
C3 0.4127(3) 0.7185(8) 0.94397(10) 0.0227(7) 
C4 0.5437(3) 0.6883(8) 0.93331(9) 0.0224(7) 
C5 0.5683(3) 0.5329(8) 0.89302(9) 0.0201(7) 
C6 0.7063(3) 0.5111(8) 0.88220(10) 0.0233(7) 
C7 0.7360(3) 0.4384(8) 0.83702(10) 0.0232(7) 
C8 0.8608(3) 0.2861(8) 0.83088(10) 0.0242(7) 
C9 0.8897(3) 0.2065(9) 0.78884(11) 0.0290(8) 
C10 0.7991(3) 0.2871(10) 0.75218(11) 0.0358(9) 
C11 0.6795(3) 0.4616(9) 0.75720(11) 0.0322(8) 
C12 0.6488(3) 0.5328(9) 0.79883(10) 0.0255(7) 
C13 0.4558(3) 0.3930(8) 0.86548(10) 0.0223(7) 
C14 0.3272(3) 0.4191(8) 0.87609(10) 0.0231(7) 
 
Table 4. Bond lengths (Å) for 
Benzophenone8.  
O1-C2 1.364(4) O1-C1 1.424(4) 
O2-C4 1.355(4) O2-H2 0.84 
O3-C6 1.267(4) O4-C8 1.360(4) 
O4-H4 0.84 O5-C14 1.370(4) 
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O5-H5 0.84 C1-H1A 0.98 
C1-H1B 0.98 C1-H1C 0.98 
C2-C3 1.376(4) C2-C14 1.402(4) 
C3-C4 1.391(4) C3-H3 0.95 
C4-C5 1.415(4) C5-C13 1.413(4) 
C5-C6 1.458(4) C6-C7 1.471(4) 
C7-C12 1.402(4) C7-C8 1.409(4) 
C8-C9 1.382(4) C9-C10 1.373(5) 
C9-H9 0.95 C10-C11 1.395(5) 
C10-H10 0.95 C11-C12 1.370(4) 
C11-H11 0.95 C12-H12 0.95 
C13-C14 1.366(4) C13-H13 0.95 
 
Table 5. Bond angles (°) for Benzophenone8.  
C2-O1-C1 118.3(2) C4-O2-H2 109.5 
C8-O4-H4 109.5 C14-O5-H5 109.5 
O1-C1-H1A 109.5 O1-C1-H1B 109.5 
H1A-C1-H1B 109.5 O1-C1-H1C 109.5 
H1A-C1-H1C 109.5 H1B-C1-H1C 109.5 
O1-C2-C3 124.5(3) O1-C2-C14 114.3(3) 
C3-C2-C14 121.1(3) C2-C3-C4 119.4(3) 
C2-C3-H3 120.3 C4-C3-H3 120.3 
O2-C4-C3 117.2(3) O2-C4-C5 121.9(3) 
C3-C4-C5 120.9(3) C13-C5-C4 117.4(3) 
C13-C5-C6 122.7(3) C4-C5-C6 119.8(3) 
O3-C6-C5 119.1(3) O3-C6-C7 118.5(3) 
C5-C6-C7 122.4(3) C12-C7-C8 117.2(3) 
C12-C7-C6 123.0(3) C8-C7-C6 119.7(3) 
O4-C8-C9 117.3(3) O4-C8-C7 121.9(3) 
C9-C8-C7 120.8(3) C10-C9-C8 120.3(3) 
C10-C9-H9 119.8 C8-C9-H9 119.8 
C9-C10-C11 119.9(3) C9-C10-H10 120.0 
C11-C10-H10 120.0 C12-C11-C10 119.8(3) 
C12-C11-H11 120.1 C10-C11-H11 120.1 
C11-C12-C7 121.6(3) C11-C12-H12 119.2 
C7-C12-H12 119.2 C14-C13-C5 121.7(3) 
C14-C13-H13 119.2 C5-C13-H13 119.2 
C13-C14-O5 118.8(3) C13-C14-C2 119.3(3) 
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O5-C14-C2 121.8(3) 
  
 
Table 6. Anisotropic atomic displacement parameters (Å2) 
for Benzophenone8.  
The anisotropic atomic displacement factor exponent takes the 
form: -2pi2[ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
 
U11 U22 U33 U23 U13 U12 
O1 0.0211(12) 0.0428(14) 0.0243(12) -0.0067(11) 0.0073(9) 0.0006(10) 
O2 0.0234(12) 0.0499(15) 0.0205(12) -0.0117(11) 0.0002(10) 
-
0.0046(12) 
O3 0.0239(12) 0.0605(17) 0.0235(13) -0.0080(12) 0.0014(10) 
-
0.0012(12) 
O4 0.0210(12) 0.0523(16) 0.0262(13) 0.0017(12) 0.0024(10) 0.0038(11) 
O5 0.0189(11) 0.0521(16) 0.0224(12) -0.0102(11) 0.0039(9) 
-
0.0062(11) 
C1 0.0297(18) 0.039(2) 0.0295(19) -0.0084(17) 0.0124(15) 
-
0.0010(16) 
C2 0.0215(17) 0.0290(18) 0.0211(17) 0.0053(15) 0.0067(13) 0.0026(14) 
C3 0.0277(17) 0.0259(18) 0.0153(16) -0.0004(14) 0.0058(13) 0.0007(14) 
C4 0.0253(17) 0.0285(17) 0.0134(16) -0.0008(14) 0.0019(13) 
-
0.0018(14) 
C5 0.0215(16) 0.0223(16) 0.0167(16) 0.0002(13) 0.0031(13) 0.0011(13) 
C6 0.0239(17) 0.0267(18) 0.0189(17) -0.0010(14) 0.0016(14) 
-
0.0020(14) 
C7 0.0227(17) 0.0265(17) 0.0209(17) -0.0009(14) 0.0053(13) 
-
0.0035(14) 
C8 0.0203(16) 0.0285(18) 0.0236(17) -0.0018(15) 0.0020(13) 
-
0.0054(14) 
C9 0.0262(17) 0.034(2) 0.0297(19) -0.0042(16) 0.0142(15) 
-
0.0055(15) 
C10 0.037(2) 0.049(2) 0.0229(18) -0.0083(17) 0.0124(16) 
-
0.0149(18) 
C11 0.034(2) 0.042(2) 0.0203(18) 0.0027(16) 0.0021(14) -0.0116(17) 
C12 0.0244(17) 0.0298(18) 0.0224(18) 0.0008(15) 0.0036(14) -0.0037(15) 
C13 0.0246(17) 0.0254(18) 0.0176(16) -0.0011(14) 0.0056(13) 0.0002(13) 
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U11 U22 U33 U23 U13 U12 
C14 0.0237(17) 0.0274(17) 0.0178(17) 0.0007(14) 0.0013(13) -0.0016(14) 
 
Table 7. Hydrogen atomic coordinates 
and isotropic atomic displacement 
parameters (Å2) for Benzophenone8.  
 
x/a  y/b  z/c  U(eq) 
H2 0.7204 0.7575 0.9554 0.047 
H4 0.9360 0.3030 0.8888 0.05 
H5 0.1512 0.2846 0.8601 0.047 
H1A 0.1863 0.6566 0.9877 0.048 
H1B 0.0434 0.7716 0.9613 0.048 
H1C 0.1736 1.0141 0.9608 0.048 
H3 0.3971 0.8278 0.9708 0.027 
H9 0.9728 0.0956 0.7853 0.035 
H10 0.8178 0.2240 0.7234 0.043 
H11 0.6194 0.5310 0.7318 0.039 
H12 0.5665 0.6489 0.8019 0.031 
H13 0.4700 0.2778 0.8389 0.027 
 
2. Xanthone9 
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A yellow block-like specimen of C14H10O5, approximate dimensions 0.10 mm x 0.13 mm 
x 0.31 mm, was used for the X-ray crystallographic analysis. Crystal was selected under 
the microscope and covered with PARATONE oil. After that sample was mounted in 
diffractometer under the stream of cold nitrogen.  The X-ray intensity data were 
measured using BRUKER APEX2 CCD diffractometer. 
The total exposure time was 8.98 hours. The frames were integrated with the Bruker 
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SAINT software package using a narrow-frame algorithm. The integration of the data 
using a monoclinic unit cell yielded a total of 8733 reflections to a maximum θ angle of 
28.53° (0.74 Å resolution), of which 2574 were independent (average redundancy 3.393, 
completeness = 92.6%, Rint = 3.24%, Rsig = 3.51%) and 1877 (72.92%) were greater than 
2σ(F2). The final cell constants of a = 8.268(3) Å, b = 4.8051(19) Å, c = 27.536(11) Å, β 
= 91.174(4)°, volume = 1093.7(8) Å3, are based upon the refinement of the XYZ-
centroids of 2349 reflections above 20 σ(I) with 5.696° < 2θ < 55.52°. Data were 
corrected for absorption effects using the multi-scan method (SADABS). The ratio of 
minimum to maximum apparent transmission was 0.780. The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.9636 and 0.9880. 
 
All non-hydrogen atoms were refined in full-matrix anisotropic approximation based on 
F2 . All expected hydrogen atoms were placed on a calculated positions and were refined 
in isotropic approximation using "riding" model. The Uiso(H) values have been set at 
1.2  - 1.5  times the Ueq value of the carrier atom. with 175 variables converged at R1 = 
4.38%, for the observed data and wR2 = 13.92% for all data. The goodness-of-fit was 
0.950. The largest peak in the final difference electron density synthesis was 0.257 e-/Å3 
and the largest hole was -0.245 e-/Å3 with an RMS deviation of 0.052 e-/Å3. On the basis 
of the final model, the calculated density was 1.568 g/cm3 and F(000), 536 e-. 
 
Table 1. Sample and crystal data for Xanthone9.  
Chemical formula  C14H10O5 
Formula weight  258.22 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal size  0.10 x 0.13 x 0.31 mm 
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Crystal habit  yellow block 
Crystal system  monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions  a = 8.268(3) Å  α = 90° 
 
b = 4.8051(19) Å  β = 91.174(4)° 
 
c = 27.536(11) Å  γ = 90° 
Volume  1093.7(8) Å3 
 
Z  4 
Density (calculated)  1.568 Mg/cm3 
Absorption coefficient  0.121 mm-1 
F(000)  536 
 
Table 2. Data collection and structure refinement for 
Xanthone9.  
Theta range for data 
collection  1.48 to 28.53° 
Index ranges  -10<=h<=11, -6<=k<=6, -37<=l<=36 
Reflections collected  8733 
Independent reflections 2574 [R(int) = 0.0324] 
Coverage of 
independent reflections  92.6% 
Absorption correction  multi-scan 
Max. and min. 
transmission  0.9880 and 0.9636 
Structure solution 
technique  direct methods 
Structure solution 
program  SHELXS-97 (Sheldrick, 2008) 
Refinement method  Full-matrix least-squares on F2 
Refinement program  SHELXL-97 (Sheldrick, 2008) 
Function minimized  Σ w(Fo2 - Fc2)2 
Data / restraints / 
parameters  2574 / 0 / 175 
Goodness-of-fit on F2 0.950 
Final R indices  1877 data; I>2σ(I)  
R1 = 0.0438, wR2 = 
0.1223 
 
all data  R1 = 0.0662, wR2 = 0.1392 
Weighting scheme  w=1/[σ2(Fo2)+(0.0869P)2+0.2651P] 
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where P=(Fo2+2Fc2)/3 
Largest diff. peak and 
hole  0.257 and -0.245 eÅ
-3
 
R.M.S. deviation from 
mean  
0.052 eÅ-3 
 
Table 3. Atomic coordinates and 
equivalent isotropic atomic displacement 
parameters (Å2) for Xanthone9.  
U(eq) is defined as one third of the trace of 
the orthogonalizedUij tensor.  
 
x/a  y/b  z/c  U(eq) 
O1 0.72057(14) 0.2127(3) 0.42467(5) 0.0300(3) 
O2 0.01459(13) 0.5936(2) 0.33145(4) 0.0237(3) 
O3 0.73622(15) 0.8314(3) 0.35324(5) 0.0314(3) 
O4 0.44465(14) 0.7914(3) 0.40097(4) 0.0269(3) 
O5 0.29353(14) 0.1533(3) 0.45272(5) 0.0297(3) 
C1 0.7054(2) 0.4096(4) 0.46361(7) 0.0305(4) 
C2 0.8696(2) 0.1086(4) 0.41577(6) 0.0230(4) 
C3 0.8719(2) 0.9083(4) 0.37884(6) 0.0227(4) 
C4 0.0185(2) 0.7881(3) 0.36795(6) 0.0203(3) 
C5 0.1548(2) 0.4599(3) 0.31956(6) 0.0209(3) 
C6 0.1403(2) 0.2653(3) 0.28203(6) 0.0254(4) 
C7 0.2760(2) 0.1203(4) 0.26834(6) 0.0272(4) 
C8 0.4250(2) 0.1642(4) 0.29192(6) 0.0266(4) 
C9 0.4388(2) 0.3588(4) 0.32863(6) 0.0252(4) 
C10 0.3034(2) 0.5129(3) 0.34260(6) 0.0214(4) 
C11 0.31352(19) 0.7268(3) 0.38033(6) 0.0211(4) 
C12 0.16380(19) 0.8608(3) 0.39239(6) 0.0198(3) 
C13 0.1571(2) 0.0691(3) 0.42881(6) 0.0228(4) 
C14 0.0110(2) 0.1892(3) 0.44049(6) 0.0245(4) 
 
Table 4. Bond lengths (Å) for Xanthone9.  
O1-C2 1.357(2) O1-C1 1.437(2) 
O2-C5 1.371(2) O2-C4 1.3723(19) 
O3-C3 1.363(2) O3-H3 0.84 
O4-C11 1.253(2) O5-C13 1.356(2) 
O5-H5 0.84 C1-H1A 0.98 
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C1-H1B 0.98 C1-H1C 0.98 
C2-C14 1.396(2) C2-C3 1.401(2) 
C3-C4 1.382(2) C4-C12 1.409(2) 
C5-C10 1.394(2) C5-C6 1.397(2) 
C6-C7 1.380(2) C6-H6 0.95 
C7-C8 1.397(3) C7-H7 0.95 
C8-C9 1.380(2) C8-H8 0.95 
C9-C10 1.403(2) C9-H9 0.95 
C10-C11 1.463(2) C11-C12 1.440(2) 
C12-C13 1.419(2) C13-C14 1.383(2) 
C14-H14 0.95 
  
 
Table 5. Bond angles (°) for Xanthone9.  
C2-O1-C1 118.10(13) C5-O2-C4 119.10(13) 
C3-O3-H3 109.5 C13-O5-H5 109.5 
O1-C1-H1A 109.5 O1-C1-H1B 109.5 
H1A-C1-H1B 109.5 O1-C1-H1C 109.5 
H1A-C1-H1C 109.5 H1B-C1-H1C 109.5 
O1-C2-C14 124.35(15) O1-C2-C3 114.23(14) 
C14-C2-C3 121.41(15) O3-C3-C4 119.39(15) 
O3-C3-C2 122.57(15) C4-C3-C2 118.03(15) 
O2-C4-C3 115.84(14) O2-C4-C12 121.75(14) 
C3-C4-C12 122.41(15) O2-C5-C10 123.17(15) 
O2-C5-C6 115.44(14) C10-C5-C6 121.38(15) 
C7-C6-C5 118.81(16) C7-C6-H6 120.6 
C5-C6-H6 120.6 C6-C7-C8 120.72(16) 
C6-C7-H7 119.6 C8-C7-H7 119.6 
C9-C8-C7 120.13(16) C9-C8-H8 119.9 
C7-C8-H8 119.9 C8-C9-C10 120.25(16) 
C8-C9-H9 119.9 C10-C9-H9 119.9 
C5-C10-C9 118.65(15) C5-C10-C11 119.27(15) 
C9-C10-C11 122.08(15) O4-C11-C12 121.64(15) 
O4-C11-C10 122.19(15) C12-C11-C10 116.16(14) 
C4-C12-C13 117.87(15) C4-C12-C11 120.48(15) 
C13-C12-C11 121.65(14) O5-C13-C14 118.97(15) 
O5-C13-C12 120.62(15) C14-C13-C12 120.41(15) 
C13-C14-C2 119.85(15) C13-C14-H14 120.1 
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C2-C14-H14 120.1 
  
 
Table 6. Anisotropic atomic displacement parameters (Å2) 
for Xanthone9.  
The anisotropic atomic displacement factor exponent takes the 
form: -2pi2[ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
 
U11 U22 U33 U23 U13 U12 
O1 0.0247(6) 0.0339(7) 0.0314(7) -0.0113(5) 0.0006(5) 0.0051(5) 
O2 0.0238(6) 0.0234(6) 0.0241(6) -0.0061(5) 
-
0.0006(4) 0.0018(5) 
O3 0.0206(6) 0.0421(8) 0.0315(7) -0.0129(6) 
-
0.0001(5) 0.0003(5) 
O4 0.0216(6) 0.0295(7) 0.0294(6) -0.0038(5) 
-
0.0014(5) 
-
0.0004(5) 
O5 0.0244(6) 0.0315(7) 0.0329(7) -0.0111(5) 
-
0.0031(5) 
-
0.0010(5) 
C1 0.0347(10) 0.0297(10) 0.0274(9) -0.0056(7) 0.0060(7) 0.0056(8) 
C2 0.0236(8) 0.0227(8) 0.0230(8) 0.0003(6) 0.0029(6) 0.0017(6) 
C3 0.0200(8) 0.0244(8) 0.0235(8) -0.0009(7) 
-
0.0005(6) 
-
0.0014(6) 
C4 0.0267(8) 0.0171(8) 0.0174(8) -0.0002(6) 0.0024(6) 
-
0.0009(6) 
C5 0.0241(8) 0.0177(8) 0.0210(8) 0.0027(6) 0.0039(6) -0.0003(6) 
C6 0.0297(9) 0.0232(9) 0.0232(8) -0.0006(7) 
-
0.0014(7) 
-
0.0007(7) 
C7 0.0366(10) 0.0218(8) 0.0233(8) -0.0022(7) 0.0034(7) 0.0009(7) 
C8 0.0293(9) 0.0229(9) 0.0280(9) 0.0018(7) 0.0072(7) 0.0038(7) 
C9 0.0260(9) 0.0225(8) 0.0271(9) 0.0024(7) 0.0014(7) -0.0002(7) 
C10 0.0259(9) 0.0180(8) 0.0203(8) 0.0032(6) 0.0024(6) -0.0001(6) 
C11 0.0227(8) 0.0194(8) 0.0212(8) 0.0032(6) 0.0013(6) -
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U11 U22 U33 U23 U13 U12 
0.0020(6) 
C12 0.0217(8) 0.0185(8) 0.0192(8) 0.0020(6) 0.0014(6) -0.0017(6) 
C13 0.0249(8) 0.0215(8) 0.0219(8) -0.0003(6) 
-
0.0006(6) 
-
0.0034(6) 
C14 0.0288(9) 0.0210(8) 0.0237(8) -0.0042(7) 0.0009(7) 
-
0.0005(7) 
 
Table 7. Hydrogen atomic coordinates 
and isotropic atomic displacement 
parameters (Å2) for Xanthone9.  
 
x/a  y/b  z/c  U(eq) 
H3 -0.3444 0.8422 0.3712 0.047 
H5 0.3729 1.0619 0.4428 0.044 
H1A -0.2585 1.3233 0.4942 0.046 
H1B -0.4080 1.4664 0.4661 0.046 
H1C -0.2277 1.5732 0.4571 0.046 
H6 0.0388 0.2335 0.2662 0.03 
H7 0.2680 -0.0109 0.2426 0.033 
H8 0.5170 0.0600 0.2827 0.032 
H9 0.5405 0.3885 0.3445 0.03 
H14 0.0069 1.3264 0.4653 0.029 
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CHAPTER 3: The Preparation of Ketone Constituents  
from Echinacea pallida 
 
Introduction 
 Echinacea is a genus of herbaceous flowering plants in the daisy family, 
Asteraceae. The nine species it contains are commonly called purple coneflowers, but 
only three of these are used for medicinal purposes.  Echinacea angustifolia, Echinacea 
pallida, and Echinacea purpurea are the main Echinacea species and have been used to 
treat infections and enhance the immune system.1 Echinacea has ranked among the 
leading botanical supplements sold worldwide. Commercial Echinacea is often a mixture 
of species and there is no standardization of the chemical components. There are some 
differences in the constituents of Echinacea across the species and their respective plant 
parts (Table1). 
Table 1.Major constituents of Echinacea species used medicinally2 
Species Plant part Constituents Comment 
Echinacea purpurea Aerial parts Alkamides; caffeic acid 
esters, mainly cichoric 
acid; 
polysaccharides; 
polyacetylenes 
Echinacoside is not 
present 
Echinacea angustifolia Roots Alkamides; caffeic acid 
esters, particularly 
echinacoside; cynarin; 
polysaccharides; 
polyacetylenes 
Cynarin is 
characteristic 
of E. angustifolia 
Echinacea pallida Roots Caffeic acid esters, 
particularly echinacoside; 
polysaccharides; 
polyacetylenes (distinctive 
series) 
Alkamides largely 
absent 
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 Alkamides are main components of Echinacea angustifolia and Echinacea 
purpurea, in which mainly isobutylamides of straight chain fatty acids with double bonds 
and triple bonds. Bohlmann and Bauer have revealed the structure, chemistry and 
biological activities of these alkamides.3 Alkamide constituents in Echinaceaare shown in 
Figure 1.4 The major constituents ofEchinacea  pallida are ketonecompounds which are 
shown in Figure 2.5 
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Figure 1. Main alkamides in Echinacea species 
 
 
Figure 2. Ketones in Echinacea pallida 
 Ketones 22 and 24 from Echinacea pallida exhibit a range of biological 
activities.6 Recently, Chicca and co-workers reported that 24 showed a concentration 
58 
 
dependent cytotoxicity on several human cancer cell lines, including leukemia (Jurkat 
and HL-60), breast carcinoma (MCF-7), and melanoma (MeWo) cells.7 Binns has 
reported that the ketones from Echinacea pallida are potent antifungal agents.8 Related 
acetylenic ketones have been reported by Bohlmannin Centaurea ferox roots.9 Despite the 
potential value of theketones from Echinacea pallida, few reports of synthesis of 
authentic standards or analogs have been reported. Crombie and co-workers reported the 
first syntheses of related amides using organometallic coupling reactions.10 Wailes has 
also reported the synthesis of related dienamides.11 Kraus reported the synthesis of ketone 
2212 in 2005 and Benvenuti and Prati reported a clever synthesis of ketone 24 in 2008.13 
Both strategies chose 1-hexyne as the same starting material and took 12 steps and 11 
steps with the overall yields 7% and 25% (Scheme 1) respectively. The number of steps 
and low overall yield limited the amount of both ketones that could be prepared for 
biological testing. We report herein a more efficient synthesis via a phosphonium salt 
route. 
 
 
Scheme 1 
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Results and Discussion 
 Due to the similarity of ketone 22 and 24, we thought we could synthesize both 
compounds by the same strategy. Retro-synthetic analysis is shown in Scheme 2. We 
chose Wittig reaction as a key step for synthesizing 22 and 24 by coupling of different 
phosphonium salts 1 and 2 with the same aldehyde 3.14 Phosphonium salts 1 and 2 were 
eventually from the same starting material 4. 
 
OH
Cl
IPh3P
OH
PPh3I
OO
3
O
H
O
known compound
+ +
22 24
1 2
4 4
O
 
Scheme 2 Retrosynthesis 
 
 Alcohol 5, prepared in one step from 4 by the method of Kende,15 was converted 
into phosphonium salt 1 in two steps. Phosphonium salt 1 underwent an exclusively cis-
selective Wittig reaction15 with aldehyde 3 to generate a dieneyne 7 in 60% yields. 
Transformation of the chloroalkene into anacetylene using n-Butyl lithium at -78°C16 was 
a clean reaction. There was no evidence of products derived from deprotonation of the 
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methylene group between theacetylene and the alkene. The ketal protecting group was 
removed with HCl, providing ketone 22 in 24% overall yield from 4 over six steps 
(Scheme 3). 
 
 
Scheme 3 Synthesis of Ketone 22 
 
 Tosylate 9, prepared in one step from 4,17 was coupled with cis-1-bromopropene 
afforded tosylate 10 that could be converted into phosphonium salt 11 in two steps. The 
cis-selective Wittig reaction of 2 with aldehyde 3 gave ketal 12 in 76% yield. Hydrolysis 
of ketal 12 with HCl produced ketone 24 in 31% overall yield from 4 over six steps 
(Scheme 3). 
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Scheme 4 Synthesis of Ketone 24 
Conclusion 
 The strategy described above represents a significant improvement over the 
previous synthetic routes. The route to ketones 22 and 24 is direct and quite flexible with 
regard to the introduction of additional functional groups. 
 
Experimental 
 Unless otherwise noted, materials were obtained from commercial suppliers and 
used without purification. All 1H and 13C NMR spectra were recorded at 300MHz and 
100 MHz respectively. High resolution mass spectra were recorded on a Q-TOF mass 
spectrometer.Standard grade silica gel (60 Å, 32-63 µm) was used for flash column 
chromatography. 
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Compound 1 
 To 7 mL of dry dichloromethane were added in order: triphenylphosphine (473 
mg, 1.8mmol), imidazole (123 mg, 1.8 mmol), and iodine (458 mg, 1.8 mmol). A 
solution of compound 5 (217mg,1.6 mmol) in 7 mL of dry dichloromethane was added. 
The mixture was stirred at room temperature under argon for 2.5 h. The solvent was 
removed in vacuo and the residue was purified by silica gel flash chromatography 
(Hexanes/EtOAc = 1:1) to give the iodide (335 mg, 87% yield). A solution of the iodide 
(335 mg,1.4 mmol) and triphenylphosphine (367 mg,1.4 mmol) in 10 mL of acetonitrile 
was boiled for 24 h. The solvent was removed in vacuo to give compound 1 (711 mg, 100% 
yield). Compound 1 is pure enough for next one without further purification. 
1H NMR (300 MHz, CDCl3): 2.83-2.95 (m, 2H), 3.77-3.85 (m,2H), 5.35-5.38 (d, J=9.0 
Hz, 1H), 6.09-6.11 (d, J=6.0 Hz, 1H),7.54-7.74 (m, 15H). 
 
Compound 2 
 A solution of compound 10 (116 mg, 0.44 mmol) and NaI (116 mg, 0.77 mmol) 
in 12 mL of acetone was boiled for 6 h. After cooling to room temperature, the solution 
was treated with H2O and extracted with EtOAc. The combined organic layers were dried 
over Na2SO4. After removing solvents in vacuo, the residue was purified by flash 
chromatography (Hexanes/EtOAc = 4:1) to give theiodide (86 mg, 89% yield). A 
solution of the iodide (85 mg,0.39 mmol) and triphenylphosphine (102 mg, 0.39 mmol) 
in 5 mL of acetonitrile was boiled for 24 h. The solvent was removed in vacuo to give 
compound 11 (188 mg, 100% yield). Compound 11 is pure enough for next one without 
further purification. 
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1H NMR (300 MHz, CDCl3): 1.46-1.49 (dd, J=3.0, 6.0 Hz, 3H),2.78-2.89 (m, 2H), 3.71-
3.79(m, 2H), 4.82-4.85 (d, J=9.0 Hz, 1H),5.58-5.69 (m, 1H), 7.52-7.70 (m, 15H). 
 
Compound 7 
 To a solution of compound 1 (241 mg, 0.50 mmol) in 7 mL of dry THF was 
added 1.0 M sodium bis(trimethylsilyl)amide (NaHMDS) (0.5 mL) at -78 °C under argon. 
The mixture was stirred at -78 °C for 20 min. A solution of compound 3 (79 mg, 0.46 
mmol) in 3 mL of dry THF was added. The mixture was warmed to room temperature in 
1.5 h and stirred at room temperature for 12 h. Saturated NH4Cl solution was added to 
quench the reaction. The aqueous layer was extracted three times with 5 mL of ethyl 
acetate. The combined organic layers were dried over Na2SO4. After removing solvents 
in vacuo, the residue was purified by preparative TLC (hexanes/EtOAc = 10:1) to give 
compound 7 (56 mg, 60% yield). 
1H NMR (300 MHz, CDCl3): 1.30-1.43 (m, 9H), 1.58-1.65 (m,2H), 2.03-2.09 (m, 
2H),3.13-3.14 (d, J=3.0 Hz, 2H), 3.88-3.98 (m,4H), 5.41-5.54 (m, 2H), 5.82-5.86 (m, 
1H),6.28-6.31 (d, J=9.0 Hz,1H).  
13C NMR (100 MHz, CDCl3): 18.3, 24.0, 24.2, 27.4, 29.5, 29.7,39.4, 64.8, 74.5, 97.5, 
110.3,112.6, 123.6, 127.2, 132.5.  
HRMS (M+1):calculated for C16H24ClO2: 283.1459; found: 283.1458. 
 
Compound 10 
 To a solution of cis-1-bromo-1-propene (0.51 mL, 6 mmol) in12 mL of Et2NH 
were added CuI (60 mg, 0.3 mmol) and Pd(PPh3)2Cl2 (421 mg, 0.6 mmol) at room 
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temperature under argon.The mixture was stirred at room temperature for 5 min. A 
solutionof compound 9 (1344mg, 6 mmol) in 18 mL of Et2NH was added. The mixture 
was stirred at room temperature for 10 h. The solution was treated with H2O and 
extracted with EtOAc. The combined organic layers were dried over Na2SO4. After 
removing solvents in vacuo, the residue was purified by flash chromatography 
(Hexanes/EtOAc = 4:1) to give compound 10 (872 mg, 55% yield). 
1H NMR (300 MHz, CDCl3): 1.75-1.77 (d, J=6.0 Hz, 3H), 2.41 (s,3H), 2.65-2.71 (td, 
J=3.0, 9.0Hz, 2H), 4.06-4.11 (t, J=9.0 Hz, 2H),5.31-5.37 (m, 1H), 5.84-5.94 (m, 1H), 
7.30-7.33 (d, J=9.0Hz, 2H),7.75-7.78 (d, J=9.0 Hz, 2H).  
13C NMR (100 MHz, CDCl3): 15.9, 20.5,21.7, 68.0, 79.4, 88.3, 109.7, 128.0, 130.0, 
132.9,138.5, 145.0.  
HRMS(M+1): calculated for C14H17O3S: 265.0893; found: 265.0890. 
 
Compound 12 
 To a solution of compound 2 (188 mg, 0.39 mmol) in 5 mL of dry THF was 
added 1.0M sodium bis(trimethylsilyl)amide (NaHMDS) (0.4 mL) at -78 °C under argon. 
The mixture was stirredat -78 °C for 20 min. A solution of compound 3 (118 mg,0.63 
mmol) in 3 mL of dry THF was added. The mixture was warmed to room temperature in 
1.5 h and stirred at room temperature for 12 h. Saturated NH4Cl solution was added to 
quench reaction. The aqueous layerwas extracted three times with 5 mL of ethyl acetate. 
The combined organic layers were driedover Na2SO4. After removing solvents in vacuo, 
the residue was purified by preparative TLC (Hexanes/EtOAc = 4:1) to give compound 
12 (78 mg,76% yield). 
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1H NMR (300 MHz, CDCl3): 1.30-1.42 (m, 9H), 1.59-1.64 (m,2H),1.82-1.85 (dd, J=3.0, 
6.0 Hz,3H), 2.02-2.08 (m, 2H), 3.08-3.09(d, J=3.0 Hz, 2H), 3.87-3.97 (m, 4H), 5.42-5.47 
(m, 3H),5.83-5.93(m, 1H).  
13C NMR (100 MHz, CDCl3): 16.0, 18.2, 23.9, 24.2, 27.9, 29.5,29.7, 39.4, 64.8, 77.1, 
93.2,110.3, 110.5, 124.5, 131.8, 137.4.  
HRMS(M+1): calculated for C17H27O2: 263.2006; found: 263.2004. 
 
Ketone 22 
 To a solution of compound 7 (56 mg, 0.2 mmol) in 3 mL of dry THF was added 
2.5 M n-BuLi (0.08 mL) at -78° C under argon. The mixture was stirred at -78 °C for 30 
min. Saturated NH4Cl solution was added to quench reaction. The aqueous layer was 
extracted three times with 5 mL of ethyl acetate. The combined organic layers were dried 
over Na2SO4. After removing solvents in vacuo, the residue was purified by silica gel 
flash chromatography (Hexanes/EtOAc = 4:1) to give compound 8 (26 mg, 53% yield). 
To the solution of compound 8  (26 mg, 0.11 mmol) in 1.5 mL of THF was added 1.5 mL 
of 1 N HCl. The mixture was stirred at room temperature for 1 h and quenched with 
water. The aqueous layer was extracted three times with 5 mL of ethyl acetate. The 
combined organic layers were dried over Na2SO4. After removing solvents in vacuo, the 
residue was purified by flash chromatography (Hexanes/EtOAc = 4:1) to give compound 
22 (19 mg, 89% yield). Both 1H and 13C NMR spectra of 22 were identical to spectra 
reported in the literature.12 
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Ketone 24 
 To the solution of compound 12 (78 mg, 0.3 mmol) in 4 mL of THF was added 4 
mL of 1N HCl. The mixture was stirred at room temperature for 1 h. Water was added to 
quench thereaction. The aqueous layer was extracted three times with 5 mL of ethyl 
acetate. The combined organic layers were dried over Na2SO4. After removing solvents 
in vacuo, the residue was purified by flash chromatography (Hexanes/EtOAc = 4:1) to 
give compound 24 (56 mg, 86%yield). Both 1H and 13C NMR spectra of 24 were 
identical to spectra reported in the literature.13 
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CHAPTER 4: Synthesis of Uliginosins A and B 
 
Introduction 
 Uliginosin A (1) and Uliginosin B (2) shown in Figure 1 are acyl phloroglucinols 
present in Hypericum gentianoides.1-3 These acyl phloroglucinols showed antibacterial 
activity against Bacillus subtilis,4-6 Staphylococcus aureus and antifungal activity against 
Trichophyton mentagrophytes.3 Recently, Hillwig7 reported that both compounds exhibit 
anti-inflammatory and anti-HIV activity.  Because H. gentianoides is not a common 
species and can be difficult to grow, the availability of quantities of 1 and 2 depends on 
the development of an efficient synthetic route.  In 1978 Meikel and Stevens reported the 
synthesis of 18-9 and achieved the synthesis of 210-11 by oxidation of 1 with DDQ in 8% 
yield. Unfortunately, we were unable to reproduce the synthesis of 1 due to the limited 
experimental detail. We describe herein a general route for the synthesis of both 
compounds in improved yields from a common intermediate. 
 
 
Figure 1 Structures of 1 and 2 
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Results and Discussion 
 Compounds 1 and 2 are from the coupling reactions of 312 with prenyl ketone 4 
and benzopyran 5 respectively (Scheme 1). Prenyl ketone 4 and benzopyran 5 are from 
the same compound 6. Compound 3 and 6 are eventually from phloroglucinol. Scheme 2 
showed how to make compound 3. 
Scheme 1 
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Scheme 2 
 
 The synthesis of Uliginosin A (1) required the reaction of prenyl ketone 4 with 3.  
Although two syntheses of prenyl ketone 4 had been reported,13-14 the prenylation of 
isobutyrylphloroglucinol proved difficult, affording multiple products with a variety of 
bases (NaH, NaOMe and KOH).13,15,16 A new strategy was decided to protect three 
hydroxy groups first, then two metal hydrogen exchange reactons followed by 
deprotection to generate prenyl ketone 4 (Scheme 3). We chose 1,3,5-trimethoxybenzene 
as starting material. Metal hydrogen exchange followed by prenylation and another metal 
hydrogen exanchge followed by acylation generated compound 8 in good yields. But the 
demethylation proved diffcult, all attemps failed using Lewis acids and mineral acids. 
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Scheme 3 
 Wagner and Mioskowski17 mentioned an interesting reaction. They carried 
out cinnamylation of phloroglucinol in aqueous solution by using NaOH as a base, they 
could get C-alkylation product exclusively in good yields (Scheme 4). After 
deprotonation of phloroglucinol in aqueous solution, the anion was surrounded with 
water, so the O-alkylation could not happen. Only C-alkylation could occur. 
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Scheme 4 
 Based on this idea, after trying different reaction conditions, the reaction of 
isobutyryl-phloroglucinol with prenyl bromide at room temperature in ether and saturated 
aqueous Na2CO3 with copper (I) chloride as catalyst reproducibly provided a 46% yield 
of prenyl ketone 4 (Scheme 5). Initially, the connection of 4 with 3 failed, in part because 
of the limited experimental details in the Meikel and Stevens paper. After many 
experiments, the key coupling of 4 and 3 to generate Uliginosin A (1) was achieved in 63% 
yields.  The crucial experimental parameters were found to be the number of equivalents 
of the base and the temperature. 
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Scheme 5 
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 Scheme 6 showed the possible mechanism. 
 
 
Scheme 6 
 
 Benzopyran 5 was prepared by a route used by our group for the synthesis of acyl 
benzopyrans18 (Scheme 7). Ketone 7 was generated by protection of two hydroxyl groups 
of compound 6 with MOMCl, followed by selective deprotection of one MOM group 
with iodine. Base induced cyclization of ketone 7 with 3-methyl-2-butenal and 
deprotection with HCl afforded benzopyran 5. The reaction of benzopyran 5 with 3 
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afforded Uliginosin B (2) in 62% yields. 
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Scheme 7 
 
Conclusion 
 In summary, direct and reproducible syntheses of Uliginosins A and B were 
achieved.  The direct prenylation of isobutyrylphloroglucinol was solved. The availability 
of these commonly occurring acyl phloroglucinols will permit additional studies of their 
biological activity.  
 
Experimental 
 Unless otherwise noted, materials were obtained from commercial suppliers and 
used without purification. All 1H and 13C NMR spectra were recorded at 300MHz and 
100 MHz respectively.Standard grade silica gel (60 Å, 32-63 µm) was used for flash 
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column chromatography. 
Compound 1 
 To a mixture of compound 3 (25 mg, 0.095 mmol), 4 (22 mg, 0.048 mmol) and 
NaH (8 mg, 0.192 mmol) was added 3 mL of EtOH. The resulting mixture was boiled for 
45 min. After cooling to room temperature, the solvent was removed in vacuo. After 
acidifying with 3N HCl, the aqueous layer was extracted with EtOAc (5 mL × 3). The 
combined organic layers were washed by brine and dried over Na2SO4. The solvent was 
removed in vacuo. The residue was purified by silica gel chromatography 
(Hexanes:EtOAc = 1:1) to give Uliginosin A (1) (15 mg, 63% yield). The proton and 
carbon NMR were identical to the literature spectra.6 
 
Compound 2 
 To a mixture of compound 5 (30 mg, 0.065 mmol), 3 (36 mg, 0.13 mmol) and 
NaH (11 mg, 0.26 mmol) was added 3mL of EtOH. The resulting mixture was boiled for 
45 min. After cooling to room temperature, the solvent was removed in vacuo. After 
acidifying by 3N HCl, EtOAc (5mL × 3) was added to extract. The combined organic 
layers were washed by brine and dried over Na2SO4. The solvent was removed in vacuo. 
The residue was purified by silica gel chromatography (Hexanes:EtOAc = 5:1) to give 
Uliginosin B (2) (20 mg, 62% yield). The proton and carbon NMR were identical to the 
literature spectra.19 
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Compound 4 
 Prenyl bromide (0.08 mL, 0.6 mmol) was added to a two-phase mixture 
consisting of isobutyrylphloroglucinol (58 mg, 0.29 mmol) and CuCl (2 mg, 0.02 mmol) 
in ether (3 mL) and saturated aqueous Na2CO3 (3 mL). The mixture was stirred 
vigorously for 5 h at room temperature.  After acidifying with 3N HCl, the aqueous layer 
was extracted with EtOAc (5 mL × 3). The combined organic layers were washed by 
brine and dried over Na2SO4. The solvent was removed in vacuo. The residue was 
purified by silica gel chromatography (Hexanes:EtOAc = 3:1) to give pure 4 (35 mg, 46% 
yield). 
 
Compound 5 
 The solution of 12 (69 mg, 0.28 mmol) and 3-methyl-2-butenal (0.07 mL, 0.7 
mmol) in 5mL of pyridine was boiled for 16 h. After cooling to room temperature, the 
solvent was removed in vacuo. The residue was purified by silica gel chromatography 
(Hexanes:EtOAc = 5:1) to give the MOM ether of 12 (71 mg, 83% yield). To a solution 
of the MOM ether of 12 (120 mg, 0.39 mmol) in 20 mL of MeOH was added 1.3 mL of 
3N HCl. The resulting mixture was boiled for 25 min. After cooling to room temperature, 
the solvent was removed in vacuo. The residue was purified by preparative TLC 
(Hexanes:EtOAc = 5:1) to give pure 5 (83 mg, 81% yield). 
1H NMR: 6.55-6.59(1H, d, J=12.0 Hz), 5.94(1H, s), 5.41-5.44(1H, d, J=9.0 Hz), 3.81-
3.90(1H, m), 1.49(6H, s), 1.17-1.20(6H, d, J=9.0 Hz).   
13C NMR (100MHz): 19.6, 28.0, 39.4, 78.3, 96.4, 102.3, 105.2, 116.7, 124.6, 156.7, 
158.5, 166.2, 210.8. 
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Compound 12 
 To a solution of isobutyrylphloroglucinol (257 mg, 1.3 mmol) in 5 mL of CH2Cl2 
was added diisopropylethylamine (0.68mL, 3.9 mmol) at 0 °C. Chloromethylmethylether 
(2.6 mmol) was then added. The mixture was stirred at 0 ° C for 2 h. Water was added to 
quench the reaction. CH2Cl2 (5 mL × 3) was added to extract. The combined organic 
layers were washed by brine and dried over Na2SO4. The solvent was removed in vacuo. 
The residue was purified by silica gel chromatography (Hexanes:EtOAc = 1:1) to give 
the 2,4-Bis-MOM ether of isobutyrylphloroglucinol (310 mg, 84% yield). To a solution 
of the 2,4-Bis-MOM ether of isobutyrylphloroglucinol (428 mg, 1.5 mmol) in 15 mL of  
MeOH was added I2 (150 mg) at room temperature. The resulting mixture was stirred at 
room temperature for 16 h. Saturated aqueous Na2S2O3 solution was added followed by 
EtOAc (10 mL × 3). The combined organic layers were washed by brine and dried over 
Na2SO4. The solvent was removed in vacuo. The residue was purified by silica gel 
chromatography (Hexanes:EtOAc = 1:1) to give 12 (295 mg, 82% yield). 
1H NMR (300MHz): 6.08(2H, s), 5.14(2H, s), 3.86-3.95(1H, m), 3.45(3H, s), 1.17-
1.19(6H, d, J=6.0 Hz).   
13C NMR (100MHz): 19.4, 39.6, 56.6, 94.0, 96.3, 105.0, 163.2, 163.4, 211.3.   
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CHAPTER 5: GENERAL CONCLUSIONS 
 
 In this dissertation, syntheses of some biologically active natural products have 
been studied. During this process, novel synthetic methodologies have been developed. 
 
 Chapter 2 describes an efficient synthesis of Bauhinoxepin J and 
polyhydroxylated xanthones via intramolecular radical cyclization as a key step. Two 
new natural products were first made during synthesis of polyhydroxylated xanthones. 
Based on the mechanism proposed from synthesis of polyhydroxylated xanthones, a 
noval method of facile oxidation of 1,4-hydroquinones to 1,4-benzoquinones by using 
NBS was developped. 
 
 Chapter 3 describes a new, efficient and straightforward formal total synthesis of 
two ketone constituents, (Z)-tetradeca-8-en-11,13-diyn-2-one and (8Z,13Z)-pentadeca-
8,13-dien-11-yn-2-one from Echinacea pallida, employing Wittig reaction as a key step 
to generate cis double bonds. 
 
 Chapter 4 illustrates a direct route for the synthesis of Uliginosins A and B by 
using the same strategy. This strategy led to successful synthesis of two natural products 
in a straightforward fashion. 
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APPENDIX: 1H and 13C NMR Spectra 
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